These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 32376371

  • 1. Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift.
    Plum J, Bavnhøj CG, Eliasen JN, Rades T, Müllertz A.
    Eur J Pharm Biopharm; 2020 Jul; 152():35-43. PubMed ID: 32376371
    [Abstract] [Full Text] [Related]

  • 2. Development of a Video-Microscopic Tool To Evaluate the Precipitation Kinetics of Poorly Water Soluble Drugs: A Case Study with Tadalafil and HPMC.
    Christfort JF, Plum J, Madsen CM, Nielsen LH, Sandau M, Andersen K, Müllertz A, Rades T.
    Mol Pharm; 2017 Dec 04; 14(12):4154-4160. PubMed ID: 28763224
    [Abstract] [Full Text] [Related]

  • 3. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM, Boyd B, Rades T, Müllertz A.
    Eur J Pharm Sci; 2016 Aug 25; 91():31-9. PubMed ID: 27260089
    [Abstract] [Full Text] [Related]

  • 4. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L, Tajber L.
    Eur J Pharm Biopharm; 2015 Aug 25; 94():106-15. PubMed ID: 25998701
    [Abstract] [Full Text] [Related]

  • 5. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T, Hirai D, Kimura SI, Iwao Y, Itai S.
    Int J Pharm; 2018 Apr 05; 540(1-2):171-177. PubMed ID: 29447848
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Theoretical evaluation of supersaturation of amorphous solid dispersion formulations with different drug/polymer combinations using mathematical modeling.
    Hirai D, Tsunematsu H, Kimura SI, Itai S, Fukami T, Iwao Y.
    Int J Pharm; 2022 Sep 25; 625():122110. PubMed ID: 35970282
    [Abstract] [Full Text] [Related]

  • 11. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GGZ, Taylor LS.
    J Pharm Sci; 2011 Aug 25; 100(8):3316-3331. PubMed ID: 21607951
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K.
    J Pharm Sci; 2013 Jul 25; 102(7):2273-81. PubMed ID: 23658029
    [Abstract] [Full Text] [Related]

  • 13. Supersaturation in human gastric fluids.
    Bevernage J, Hens B, Brouwers J, Tack J, Annaert P, Augustijns P.
    Eur J Pharm Biopharm; 2012 May 25; 81(1):184-9. PubMed ID: 22342777
    [Abstract] [Full Text] [Related]

  • 14. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
    Xie T, Gao W, Taylor LS.
    Int J Pharm; 2017 Oct 05; 531(1):313-323. PubMed ID: 28844901
    [Abstract] [Full Text] [Related]

  • 15. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ, Kestur US, Hussain MA, Taylor LS.
    Mol Pharm; 2016 Jan 04; 13(1):223-31. PubMed ID: 26618718
    [Abstract] [Full Text] [Related]

  • 16. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
    Qian F, Wang J, Hartley R, Tao J, Haddadin R, Mathias N, Hussain M.
    Pharm Res; 2012 Oct 04; 29(10):2765-76. PubMed ID: 22315020
    [Abstract] [Full Text] [Related]

  • 17. Comparison of induction methods for supersaturation: pH shift versus solvent shift.
    Plum J, Bavnhøj C, Palmelund H, Pérez-Alós L, Müllertz A, Rades T.
    Int J Pharm; 2020 Jan 05; 573():118862. PubMed ID: 31759102
    [Abstract] [Full Text] [Related]

  • 18. Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs.
    Odeh AB, El-Sayed B, Knopp MM, Rades T, Blaabjerg LI.
    Pharmaceutics; 2023 May 26; 15(6):. PubMed ID: 37376048
    [Abstract] [Full Text] [Related]

  • 19. Effect of vinylpyrrolidone polymers on the solubility and supersaturation of drugs; a study using the Cheqsol method.
    Fornells E, Fuguet E, Mañé M, Ruiz R, Box K, Bosch E, Ràfols C.
    Eur J Pharm Sci; 2018 May 30; 117():227-235. PubMed ID: 29481859
    [Abstract] [Full Text] [Related]

  • 20. Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.
    Vo AQ, Feng X, Pimparade M, Ye X, Kim DW, Martin ST, Repka MA.
    Eur J Pharm Sci; 2017 May 01; 102():71-84. PubMed ID: 28257881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.